Citation :
The EU is also talking to French pharmaceutical firm Valneva about a potential deal for its COVID-19 vaccine candidate, two EU officials involved in the negotiations said.
Millions of doses of the Valneva vaccine, which started Phase I and II clinical trials in December, have already been booked by Britain. Before applying for approval, vaccines must prove safe and effective in large-scale Phase III trials.
|